Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Russell

Showing results (991-1000 of 1,120) with videos related to

Pageof 112
Sort By:
Bone Marrow Transplantation|October 28, 2014
Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantationB E Shaw, F Lee, S Krishnamurthy, et al.
Clinical Neuroradiology|May 20, 2020
Antiplatelet Drugs for Neurointerventions: Part 1 Clinical PharmacologySamuel Pearce, Julian T Maingard, Kenny Li, et al.
Journal of the American Society for Mass Spectrometry|May 15, 2024
Bortezomib Inhibits Open Configurations of the 20S ProteasomeLucas W Henderson, Amit K S Gautam, Edie M Sharon, et al.
Chemical Communications (Cambridge, England)|March 15, 2018
Melting proteins confined in nanodroplets with 10.6 μm light provides clues about early steps of denaturationTarick J El-Baba, Daniel R Fuller, Daniel W Woodall, et al.
Blood|June 22, 2001
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyA C Rawstron, B Kennedy, P A Evans, et al.
Haematologica|July 7, 2018
Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trialAlan K Burnett, Emma Das Gupta, Steve Knapper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Leukemia|September 15, 2016
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemiaA K Burnett, N H Russell, R K Hills, et al.
Biochemistry|May 10, 2008
Structure and function of the sterol carrier protein-2 N-terminal presequenceGregory G Martin, Heather A Hostetler, Avery L McIntosh, et al.
British Journal of Haematology|April 27, 2012
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009John A Snowden, Rachel M Pearce, Julia Lee, et al.
Pageof 112

Showing results (991-1000 of 1,120) with videos related to

Sort By:
Pageof 112
Bone Marrow Transplantation|October 28, 2014
Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantationB E Shaw, F Lee, S Krishnamurthy, et al.
Clinical Neuroradiology|May 20, 2020
Antiplatelet Drugs for Neurointerventions: Part 1 Clinical PharmacologySamuel Pearce, Julian T Maingard, Kenny Li, et al.
Journal of the American Society for Mass Spectrometry|May 15, 2024
Bortezomib Inhibits Open Configurations of the 20S ProteasomeLucas W Henderson, Amit K S Gautam, Edie M Sharon, et al.
Chemical Communications (Cambridge, England)|March 15, 2018
Melting proteins confined in nanodroplets with 10.6 μm light provides clues about early steps of denaturationTarick J El-Baba, Daniel R Fuller, Daniel W Woodall, et al.
Blood|June 22, 2001
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyA C Rawstron, B Kennedy, P A Evans, et al.
Haematologica|July 7, 2018
Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trialAlan K Burnett, Emma Das Gupta, Steve Knapper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemiaAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Leukemia|September 15, 2016
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemiaA K Burnett, N H Russell, R K Hills, et al.
Biochemistry|May 10, 2008
Structure and function of the sterol carrier protein-2 N-terminal presequenceGregory G Martin, Heather A Hostetler, Avery L McIntosh, et al.
British Journal of Haematology|April 27, 2012
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009John A Snowden, Rachel M Pearce, Julia Lee, et al.
Pageof 112